The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Belov Yu.V.

RNTsKh im. akad. B.V. Petrovskogo RAMN

Kim E.F.

Petrovsky Russian Research Center for Surgery, Moscow, Russia

Charchian É.R.

RNTsKh im. akad. B.V. Petrovskogo RAMN

Bedzhanyan A.L.

Petrovsky Russian Research Center for Surgery, Moscow, Russia

Shestakov A.L.

B.V. Petrovsky National Research Centre of Surgery, Moscow

Evseev E.P.

Petrovsky Russian Research Center for Surgery, Moscow, Russia

Eremenko A.A.

Otdelenie kardioreanimatsii i intensivnoĭ terapii FGBU RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

Nikoda V.V.

B.V. Petrovsky National Research Centre of Surgery, Moscow

Dymova O.V.

Petrovsky Russian Research Center for Surgery, Moscow, Russia

Frolova Iu.V.

RNTsKh im. akad. B.V. Petrovskogo RAMN, Moskva

The present and the future of oncocardiology team in current multi-field surgical clinic

Authors:

Belov Yu.V., Kim E.F., Charchian É.R., Bedzhanyan A.L., Shestakov A.L., Evseev E.P., Eremenko A.A., Nikoda V.V., Dymova O.V., Frolova Iu.V.

More about the authors

Read: 1752 times


To cite this article:

Belov YuV, Kim EF, Charchian ÉR, et al. . The present and the future of oncocardiology team in current multi-field surgical clinic. Russian Journal of Cardiology and Cardiovascular Surgery. 2019;12(1):5‑8. (In Russ.)
https://doi.org/10.17116/kardio2019120115

Recommended articles:
The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medi­cine. 2024;(11):141-146
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21

References:

  1. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220-241.
  2. Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53(24):2231-2247.
  3. Darby SC, Cutter DJ, Boerma M, et al. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys. 2010;76(3):656-665.
  4. ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. European Heart Journal. 2016;37:2768-2801. https://doi.org/10.1093/eurheartj/ehw211
  5. Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981-1988.
  6. Armenian SH, Hudson MM et al. International Late Effects of Childhood Cancer Guideline Harmonization Group. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16:e123-e136.
  7. Sawaya H, Sebag IA, et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012;5:596-603.
  8. Negishi K, Negishi T, Hare JL, Haluska BA, Plana JC, Marwick TH. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr. 2013;26:493-498.
  9. Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15(10):1063-1093.
  10. Chavez-MacGregor M, Niu J, Zhang N, et al. Cardiac monitoring during adjuvant trastuzumab-based chemotherapy among older patients with breast cancer. J Clin Oncol. 2015;33(19):2176-2183.
  11. Cardinale D, Sandri MT, et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation. 2004;109:2749-2754.
  12. Cardinale D, Colombo A, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981-1988.
  13. Sawaya H, Sebag IA, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107(9):1375-1380.
  14. Georgakopoulos P, Roussou P, Matsakas E, et al. Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up. Am J Hematol. 2010;85(11):894-896.
  15. Bosch X, Rovira M, Sitges M, et al. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (prevention of left Ventricular dysfunction with Enalapril and carvedilol in patients submitted to intensive Chemotherapy for the treatment of Malignant hemopathies). J Am Coll Cardiol. 2013;61(23):2355-2362.
  16. Lipshultz SE, Lipsitz SR, Sallan SE, et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol. 2002;20(23):4517-4522.
  17. Shelburne N, Adhikari B, Brell J, et al. Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities. J Natl Cancer Inst. 2014;106(9):1-9.
  18. Lenihan DJ, Westcott G. Cardio-oncology: a tremendous opportunity to improve patient care. Future Oncol. 2015;11(14):2007-2010. https://doi.org/10.2217/fon.15.99

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.